Impact Partnerships & Foundations

Building Scalable Diagnostic Access, Local Manufacturing, and Health Equity Across Africa

Millions across Africa lack access to early diagnosis — the doorway to treatment, prevention, and life-saving care. At 360Disruption, we are committed to changing that by helping nations build self-sufficient diagnostic ecosystems, powered by saliva-based molecular and protein testing technologies from Oasis Diagnostics.

We work with governments, global foundations, development partners, and innovators to bring diagnostics directly into communities — while building local manufacturing capacity that creates jobs, strengthens economies, and reduces dependency on imported medical consumables.

This is not consultancy.
This is execution for national impact.

Our Mission

To democratize early disease detection across Africa through scalable saliva diagnostics, telehealth integration, and local manufacturing powered by FDI — ensuring every community, from major cities to remote villages, gains access to timely, affordable, and non-invasive testing.

What We Do With Foundations

1. Expand Access to Diagnostics

We deploy saliva-based molecular and protein testing technologies in underserved regions where traditional blood-based diagnostics are difficult or impossible to access.

2. Build Local Manufacturing Hubs

Working with free zones and ministries, we establish assembly and production sites for diagnostic devices, creating skilled jobs and keeping healthcare spending inside the country.

3. Strengthen Public Health Systems

We support Ministries of Health with logistics, screening strategies, data systems, community health worker deployment, and scalable national rollouts.

4. Integrate Telehealth & Digital Care

With partners like Oludent Health International, we connect diagnostics to real medical follow-up — consultations, referrals, and care pathways.

5. Enable Sustainable FDI Models

We align health impact with economic development by structuring foreign direct investment to support local industry growth, job creation, and technology transfer.

Why Saliva Diagnostics?

Because it solves real constraints:

No needles

No doctors required

No cold chain

Minimal training

Perfect for rural and decentralized care

Supports PCR-level molecular testing & protein biomarkers

Scalable to millions

It is the first realistic diagnostic platform built for widespread population access in African environments.

Current Priority Countries

🇨🇩 Democratic Republic of Congo

Developing a nationwide diagnostic access and local assembly framework.

🇿🇲 Zambia

Rolling out community-level saliva testing and telehealth integration.

🇳🇬 Nigeria

Africa’s Greatest Untapped Diagnostic Market

🇬🇭 Ghana

A Stable, High-Innovation Environment for Rapid Rollout

🇸🇩 Sudan

Positioned for funding to combine diagnostics with renewable-energy-powered delivery.

Additional engagements: Ethiopia, Kenya, Ghana, Rwanda, Tanzania.

Our Model Aligns With Global Funders’ Priorities

✔ Universal Health Coverage
✔ Women’s Health & Maternal Care
✔ Early Detection & Prevention
✔ Health Equity in Rural Communities
✔ Climate-Smart, Low-Resource Diagnostics
✔ Local Manufacturing & Job Creation
✔ Digital Health & Telemedicine
✔ System-Level Strengthening
✔ Technology Transfer to Africa
✔ Economic Empowerment Through FDI

Foundations we align strongly with include:

• Global Innovation Fund (GIF)

• USAID Development Innovation Ventures (DIV)

• Skoll Foundation

• Schmidt Futures

• Omidyar Network

• Mastercard Foundation

• Africa CDC

• UNDP / UNICEF Innovation

• Africa Development Bank

• Tony Elumelu Foundation

• Mo Ibrahim Foundation

Leadership

Anjo De Heus —

Founder & Chief Strategist, 360Disruption

Anjo De Heus is a U.S./UAE-based entrepreneur, strategist, and ecosystem architect with a lifelong commitment to turning innovation into impact for communities that have historically been left behind. As the founder of 360Disruption, he leads one of the very few organizations that combine global innovation sourcing, government-level execution, and sustainable commercialization models designed specifically for emerging markets.

Throughout his 30-year career, Anjo has built, scaled, and guided ventures across the United States, the Gulf region, and Africa — uniting ideas, capital, and partnerships into systems that create lasting social and economic value. His work centers on bridging international healthtech, biotech, AI, and diagnostics innovators with regions where early detection, access to care, and preventive medicine can create immediate and measurable impact.

Anjo’s experience spans entrepreneurship, corporate strategy, and technology commercialization. Earlier in his career, he played a pivotal role in scaling multiple technology ventures — including one that grew to more than $80 million in annual revenue through strategic partnerships with SAP and HP. He later founded and co-founded successful initiatives in blockchain, AI-driven platforms, smart city technologies, and global venture incubation.

Today, he is recognized for his unique ability to work simultaneously with U.S. innovators, GCC regulators and economic development authorities, and African government leaders, acting as a translator, dealmaker, and execution partner across all three worlds. His approach ensures that life-changing technologies move beyond PowerPoints and pilot projects — into real deployment on the ground.

He currently leads diagnostic, telehealth, and population-health initiatives across Zambia, the Democratic Republic of Congo, Ethiopia, and other African countries, while maintaining close strategic engagement with government partners in the UAE where 360Disruption is based. His emphasis on FDI-driven development, local manufacturing, and capacity building has positioned 360Disruption as one of the most practical and credible platforms for health innovation scaling across Africa and the Gulf.

Anjo is also a mentor to emerging entrepreneurs, advocating for a model of innovation that prioritizes responsibility, dignity, and long-term nation-building over short-term transactional wins.

Dr. Paul D. Slowey — Founder & CEO, Oasis Diagnostics

Dr. Paul D. Slowey is a globally recognized leader in oral-fluid diagnostics and non-invasive testing — with over 35 years of experience in clinical diagnostics, pharmaceutical development, and diagnostic innovation.

As Founder & CEO of Oasis Diagnostics Corporation, Paul pioneered saliva-based diagnostic platforms that have redefined disease detection globally. His work spans molecular diagnostics (DNA/RNA), protein-based assays, immunoassays, and multiplex biomarker detection, unlocking the full potential of saliva — from infectious disease screening to oncology biomarkers, hormonal panels, and population health surveillance.

Paul earned his PhD in Organic Chemistry from the Newcastle University (UK). Over his career, he has held senior roles in leading diagnostic and pharmaceutical firms — including work in international sales, R&D, and operations — before founding Oasis Diagnostics to commercialize his innovation in oral-fluid diagnostics.

Under his leadership, Oasis Diagnostics has produced multiple patented technologies, including collection devices suited for all ages and species (infants to large animals), purification systems for high-quality nucleic acid and protein samples, and portable “point-of-care” kits. These devices are globally deployed in research labs, clinical trials, public-health screening programs, and field diagnostics — especially for hard-to-reach populations.

Significantly, during the COVID-19 pandemic, Oasis Diagnostics scaled production dramatically — winning contracts (e.g. via the National Institutes of Health, USA) under the RADx program to supply millions of saliva collection kits worldwide.

As the scientific backbone of our Africa diagnostics initiative, Paul brings:

• rigorous assay development expertise,

• proven global manufacturing and distribution track record,

• regulatory experience,

• and a deep commitment to accessible, non-invasive diagnostics for underserved communities.

With his leadership, Oasis Diagnostics provides the technical foundation, while 360Disruption provides the strategic framework, and local partners handle implementation — creating a full-stack solution ready for scale.

Dr. Oluwadara Oluwadayo — Clinical Strategist & Africa Health Systems Specialist

Dr. Oluwadara brings critical on-the-ground African health expertise, bridging the gap between advanced diagnostic technologies and real-world healthcare delivery in low-resource environments.

A seasoned clinician, technologist, and founder of Oludent Health International, he specializes in implementing scalable digital health and telemedicine systems across Africa. His work focuses on:

• frontline clinical deployment

• maternal and women’s health access

• community diagnostic networks

• digital triage and referral pathways

• rural and peri-urban health system improvement

Having worked extensively with hospitals, ministries, and private-sector health providers across the continent, Dr. Oluwadara ensures that our diagnostic programs translate into practical, culturally aligned, clinically validated solutions that work for African communities.

He is instrumental in shaping our telehealth integration, workforce training, and real-world care pathways — ensuring that diagnostics do not end at the test, but lead to treatment, referral, and long-term health outcomes.

We Are Seeking Collaborative Funding Partners

If you are a foundation, development organization, or government entity committed to health equity, early detection, and economic resilience across Africa, we invite you to partner with us.

Together, we can build a future where diagnostics are accessible to everyone — and where African nations manufacture their own health technologies.

👉 Contact us to explore partnership opportunities.
Email: impact@360disruption.com

360Disruption.com — Where Global Innovation Becomes National Impact

360Disruption is the execution engine behind some of the most ambitious expansions across the GCC and Africa.
We work with innovators, investors, and governments to commercialize breakthrough technologies, build sovereign capabilities, and open markets at national scale.

We are not consultants — we are partners in execution.
We don’t produce theory — we deliver operational outcomes.

From diagnostics to advanced manufacturing and AI-enabled infrastructure, 360Disruption turns vision into acceleration and strategy into momentum.

Build bigger. Scale faster. Execute with conviction.

 Cross-continental reach | Government partnerships | High-impact commercialization

 Ready to redefine your trajectory? Contact us today.

Made with Purpose and Precision by 360Disruption F.Z.E.
© 2026